Condition 1: Diabetes. Condition 2: Dyslipidemia. Non-insulin-dependent diabetes mellitus, Malnutrition-related diabetes mellitus Pure hypercholesterolaemia, Other hyperlipidaemia, Hyperlipidaemia, unspecified, Lipoprotein deficiency, Other disorders of lipoprotein metabolism, Disorder of lipoprotein metabolism, unspecified
Conditions
Interventions
Intervention 1: 250 g daily oat bread to patients within 3 weeks during the related phase of study consumed during the day and different meals. Intervention 2: 250 g daily barley bread to patients wit
250 g daily barley bread to patients within 3 weeks during the related phase of study consumed during the day and different meals.
250 g daily oat bread to patients within 3 weeks during the related phase of study consumed during the day and different meals.
Sponsors
National Nutrition & Food Technology Research Institute of IRAN
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with Fasting blood glucose > 126 mg/dl and at least one of lipids profile out of normal range Exclusion criteria: Patients with Cardiovascular and other systemic diseases and IDMM patients taking insulin
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum glucose levels. Timepoint: 0, 10 days after intervention. Method of measurement: Taking 5 ml fasting venous blood sample, Centrifuging samples, determining serum glucose by glucose oxidase using Auto analyzer.;Serum insuline levels. Timepoint: 0, 10 days after intervention. Method of measurement: Taking 5 ml fasting venous blood sample, Centrifuging samples, determining serum Insulin levels using Radioimmunoassay. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting serum insulin levels. Timepoint: 0, 10, 21 days after intervention. Method of measurement: Taking 5 ml fasting venous blood sample, Centrifuging samples, determining serum Insulin levels using Radioimmunoassay.;Serum lipid profiles. Timepoint: 0, 10, 21 days after intervention. Method of measurement: Taking 5 ml fasting venous blood sample, Centrifuging samples, determining serum lipid profiles using Auto analyzer.;Insulin resistance. Timepoint: 0, 10, 21 days after intervention. Method of measurement: Computing insulin resistance using HOMA: (FBS*FIns)/22.5. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contact?Shajieh Najar-Safari
Deputy for Food and Drug – Shahid Beheshti University of Medical Sciences
Outcome results
None listed